Pharmicell Co., Ltd. (KOSE: A005690)
Health Care · Biotechnology · KR
₩12,860.00
+3.71% today · +2.0% 1Y
Pharmicell Co., Ltd. (KOSE: A005690) operates in the Biotechnology industry within the Health Care sector. The company is valued at $573.98M.
Over the last twelve months the share price has gained 2.0%, trading between 8.14K and 21.15K.
Tweenvest scores Pharmicell Co., Ltd. across four factors: quality 55/100, value 65/100. Its strongest factor is value.
A005690 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $573.98M
- Revenue (TTM)
- $23.67M
- P/E
- —
- EPS
- -613.75
- Dividend yield
- —
- Beta (5Y)
- 0.61
- 52-week high
- ₩21,150.00
- 52-week low
- ₩8,140.00
- Avg volume (3M)
- —
- Shares outstanding
- 60.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medicalsystem Biotechnology Co., LtdSZSE: 300439 | $591.56M | CN¥10.31 | +0.59% |
| Guangdong Hybribio Biotech Co.,Ltd.SZSE: 300639 | $587.51M | CN¥6.27 | +1.29% |
| Blau Farmacêutica S.A.BOVESPA: BLAU3 | $584.71M | R$12.61 | +16.54% |
| Landfar Bio-medicine Co., LtdSZSE: 000504 | $580.91M | CN¥11.79 | -5.07% |
| Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163 | $563.39M | CN¥34.87 | -12.83% |
| Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373 | $561.38M | CN¥5.73 | -0.87% |
| CytomX Therapeutics, Inc.NasdaqGS: CTMX | $560.00M | $2.57 | +4.05% |
| Zhejiang Orient Gene Biotech Co., LtdSHSE: 688298 | $557.20M | CN¥19.50 | +0.67% |
Figures last refreshed Oct 11, 2026.